Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy

NCT07022743 is registered in ClinicalTrials.gov with Obafemi Awolowo University as lead sponsor.

NCT NCT07022743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07022743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy
Lead sponsor
Obafemi Awolowo University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 1, 2025
Completion date
June 30, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia (cml)